Spine Care Technologies, Inc.
Spine Care Technologies Inc. (“SCT”) was founded in March 2018 by Roland Kiser and his former banking partner James Fitzgerald. Kiser seized on the opportunity to become fully engaged in the next generation spine care technology by applying a drug-free approach to treatment of musculoskeletal pain. According to the publicly available medical research documentation, musculoskeletal pain, led by spinal disorders, costs the U.S. health care system $874 billion per year, and is the most common cause of severe long-term pain and disability. SCT markets and distributes it’s flagship product, Extentrac Elite, FDA cleared as a Medical Class II Device. Extentrac enjoys a proven record of safety and effectiveness in non-surgical, drug free, disc and spine care treatment. Health professionals worldwide have confirmed excellence in clinical outcomes in the management of low back pain in both private and hospital physical rehabilitation facilities through the utilization of Extentrac.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Kiser is supported by successful business executives with expertise in investment banking, engineering & technology inventions, operations, manufacturing, legal and medical device and sports sector.
Spine Care Technologies at a Glance…
Who We Are
We are a sophisticated medical technology equipment developer & distributor whose flagship product (Extentrac®) enjoys long standing worldwide acclaim and recognition at pain management clinics and rehabilitation hospitals.
Our MissionOur mission is to increase market penetration by leveraging the incomparable features of our existing technology and by developing the next generation of therapy devices slated to become the “CORE” and “FIRST RESORT” in Drug Free Physical Therapy, Pain Management, Chiropractic Neurological and Orthopedics interventions.
Our Strategy- Aggressively market the current flagship product (Extentrac®) in the US and globally
- Develop Next Generation Products currently not available in the market
- Engage in the battle against the Opioid Epidemic by offering “FIRST RESORT” non- medicated back-pain treatment
Our products will provide relief for millions of people who suffer from the disabling effects of acute and chronic back pain.
The unique selling proposition of our flagship product Extentrac® is it’s 3-axis spine positioning system providing the ability to treat patients from multiple (unconventional) positions.
Unlike axial spinal decompression devices, our Multi-Directional Disc Decompression system (M3D) allows distractive force from multiple directions and, therefore, allows for increased treatment options as clinicians are able to apply treatment protocols best suited for each patient’s unique spinal dysfunction which otherwise may not be available due to the constraints of a one position or one treatment protocol.
Our Track-RecordThe Extentrac product has a proven record of safety and effectiveness in non-surgical, drug-free, disc and spine care treatment for more than 20 years, without patient injury. Health professionals worldwide who utilize the Extentrac Product have confirmed excellence in clinical outcomes in the management of low back pain in both private practice and hospital physical rehabilitation facilities.
The Extentrac product has been successfully sold in over 15 countries around the world.
Our PartnersWe are aligned with very strong partners in the field of mechanical & electrical engineering, software development, manufacturing & equipment assembly, marketing and product distribution in order to deliver “THE NEXT GENERATION” of spine care technologies.